
USD
+$0.00
(+0.00%
)At Close (As of Nov 4, 2025)
$1.97B
Market Cap
42.4
P/E Ratio
2.05
EPS
$108.82
52 Week High
$71.09
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $151M |
| Total Revenue | $220M |
| Cost Of Revenue | $69M |
| Costof Goods And Services Sold | $69M |
| Operating Income | $52M |
| Selling General And Administrative | $36M |
| Research And Development | $16M |
| Operating Expenses | $99M |
| Investment Income Net | - |
| Net Interest Income | $4.7M |
| Interest Income | $4.9M |
| Interest Expense | $205K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $9.6M |
| Income Before Tax | $57M |
| Income Tax Expense | $13M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $44M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $57M |
| Ebitda | $67M |
| Net Income | $44M |
| Field | Value (USD) |
|---|---|
| Total Assets | $552M |
| Total Current Assets | $402M |
| Cash And Cash Equivalents At Carrying Value | $26M |
| Cash And Short Term Investments | $26M |
| Inventory | $56M |
| Current Net Receivables | $30M |
| Total Non Current Assets | $150M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $36M |
| Intangible Assets Excluding Goodwill | $36M |
| Goodwill | $66M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $274M |
| Other Current Assets | $7.5M |
| Other Non Current Assets | - |
| Total Liabilities | $215M |
| Total Current Liabilities | $31M |
| Current Accounts Payable | $1.8M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $2.7M |
| Total Non Current Liabilities | $184M |
| Capital Lease Obligations | $18M |
| Long Term Debt | $168M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $186M |
| Other Current Liabilities | -$4.1M |
| Other Non Current Liabilities | $259K |
| Total Shareholder Equity | $337M |
| Treasury Stock | - |
| Retained Earnings | $145M |
| Common Stock | $242K |
| Common Stock Shares Outstanding | $23M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $44M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $9.7M |
| Capital Expenditures | $7M |
| Change In Receivables | - |
| Change In Inventory | -$11M |
| Profit Loss | - |
| Cashflow From Investment | -$200M |
| Cashflow From Financing | $158M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $14M |
| Dividend Payout Common Stock | $14M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $44M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $151M |
| Total Revenue | $220M |
| Cost Of Revenue | $69M |
| Costof Goods And Services Sold | $69M |
| Operating Income | $52M |
| Selling General And Administrative | $36M |
| Research And Development | $16M |
| Operating Expenses | $99M |
| Investment Income Net | - |
| Net Interest Income | $4.7M |
| Interest Income | $4.9M |
| Interest Expense | $205K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $9.6M |
| Income Before Tax | $57M |
| Income Tax Expense | $13M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $44M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $57M |
| Ebitda | $67M |
| Net Income | $44M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-08-21 |
| Declaration Date | 2025-07-30 |
| Record Date | 2025-08-21 |
| Payment Date | 2025-09-04 |
| Amount | 0.2 |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
LeMaitre Vascular, Inc. is a prominent player in the medical device industry, specializing in products and implants for the treatment of peripheral vascular diseases on a global scale. Based in Burlington, Massachusetts, the company is dedicated to innovation and quality, providing essential tools and devices that enhance the capabilities of vascular surgeons. With a strong focus on improving patient outcomes, LeMaitre Vascular has established itself as a reliable partner for healthcare providers, maintaining a robust presence in the vascular surgery market. The company's commitment to advancing medical technology underscores its strategic importance in addressing the growing needs of patients worldwide.